In these days of the COVID-19 epidemic, many in the pharma industry are facing the challenge of accessing their customers and engaging in communication. The good news is that there are virtual solutions and approaches that are proven to deliver when in-person selling is limited or no longer an option.

The Bloc’s Dan Sontupe explores why the failure to educate patients about their conditions and treatment plans is a far bigger driver of healthcare costs than the price of prescription drugs.

TikTok: it’s the new social video app, it’s everywhere, and it’s the next generation of video.

Facebook Inc. is taking steps to reduce promotion of products based on misleading health-related claims.

FCB Health Network held its annual Innovation Week from May 7-9, 2019. Here’s a topline summary for anyone who missed the event.

What if we could look inside the minds of HCPs to see what is happening there during industry events and interactions?

As our world has evolved to become more digital, many of the companies behind some of your favorite websites such as Facebook, Google, Twitter and others capture and store highly sensitive information about your online behavior.

From the latest in VR to imaginative Social Engagement approaches, here are Ben Putman’s Top Five Digital Marketing takeaways for 2017.

Social media is integrated into the daily lives of consumers, often engaging with brands for customer service support – except when it comes to pharmaceutical companies.

Lurking behind all the sound and fury in the political realm, 2017 is bringing new opportunities to marketers that have nothing at all to do with orange hair. A whole generation of technologies are growing to maturity together – predictive targeting, virtual reality, behavioral science, interactive video, big data, and more – all of which are transforming the ways in which brands can communicate with their audiences. But of course politics will matter too in this Year One of the Trump administration, as the continuing debate over drug pricing and the impact of the new president’s policies on the pharma industry remain very much up in the ai